• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

N Engl J Med. Emergence of a Multidrug-Resistant Pandemic Influenza A (H1N1) Virus

Giuseppe

Emeritus
Emergence of a Multidrug-Resistant Pandemic Influenza A (H1N1) Virus (N Engl J Med., 1st paragraph, edited)


[Source: New England Journal of Medicine, full free text: <cite cite="http://www.nejm.org/doi/full/10.1056/NEJMc1003749?query=TOC">Emergence of a Multidrug-Resistant Pandemic Influenza A (H1N1) Virus ? NEJM</cite>. 1st paragraph, edited.]

Emergence of a Multidrug-Resistant Pandemic Influenza A (H1N1) Virus

N Engl J Med 2010; 363:1381-1382
September 30, 2010


To the Editor:


Since the outbreak of influenza A (H1N1) virus pandemic, almost 300 cases of infection with an oseltamivir-resistant influenza virus have been reported to the World Health Organization as of June 2010.1 These strains typically contain a single histidine-to-tyrosine substitution at position 275 (H275Y) of the viral neuraminidase, but they remain susceptible to zanamivir. Successful clearance of an oseltamivir-resistant virus with zanamivir, the other approved neuraminidase inhibitor, has been reported.2 We report the emergence of a pandemic influenza virus in a patient treated with neuraminidase inhibitors, with a novel resistance pattern that conferred resistance to oseltamivir, zanamivir, and peramivir.

(...)
-
------<cite cite="http://www.nejm.org/doi/full/10.1056/NEJMc1003749?query=TOC"></cite>
 
Re: N Engl J Med. Emergence of a Multidrug-Resistant Pandemic Influenza A (H1N1) Virus

H1N1 can mutate in weak patients


[Source: Straits Times, View Original Article. 9/30/10.]

BOSTON - PATIENTS with suppressed immune systems can quickly develop H1N1 flu infections that resist all known drugs, doctors in the Netherlands reported on Wednesday. The case of a 5-year-old leukemia patient who died from swine flu after the virus mutated in his body showed that people with weakened immune systems may be at greater risk of developing dangerous drug-resistant infections, and illustrated the risks of using current drugs to treat these patients, the researchers said.
-
------
 
Back
Top Bottom